Literature DB >> 18757833

Chemokines and transplant vasculopathy.

John A Belperio1, Abbas Ardehali.   

Abstract

Transplant vasculopathy (TV) remains the leading cause of late death among heart transplant recipients. Transplant vasculopathy is characterized by progressive neointimal proliferation, leading to ischemic failure of the allograft. Multiple experimental and clinical studies have shown that injury to the graft at various stages of transplantation can be a risk factor for development of transplant vasculopathy. The hallmark of cardiac allograft injury is the infiltration of leukocytes. Recruitment of leukocytes requires intercellular communication between infiltrating cells, endothelium, parenchymal cells, and components of extracellular matrix. These events are mediated via the generation of adhesion molecules, cytokines, and chemokines. The chemokines, by virtue of their specific cell receptor expression, can selectively mediate the local recruitment/activation of distinct leukocytes/cells, allowing for migration across the endothelium and beyond the vascular compartment. This report provides a comprehensive review of the chemokines that participate in the development of transplant vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757833      PMCID: PMC4214378          DOI: 10.1161/CIRCRESAHA.108.182865

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  123 in total

1.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.

Authors:  Tarek El-Sawy; Masayoshi Miura; Robert Fairchild
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

2.  Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection.

Authors:  Gabriel T Schnickel; Sam Bastani; George R Hsieh; Ali Shefizadeh; Rubina Bhatia; Michael C Fishbein; John Belperio; Abbas Ardehali
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

3.  Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production.

Authors:  S W Chensue; K S Warmington; J H Ruth; P S Sanghi; P Lincoln; S L Kunkel
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

4.  The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.

Authors:  Jorg van Loosdregt; Matthijs F M van Oosterhout; Annette H Bruggink; Dick F van Wichen; Joyce van Kuik; Erica de Koning; Carla C Baan; Nicolaas de Jonge; Frits H J Gmelig-Meyling; Roel A de Weger
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

5.  Global distribution of the CCR5 gene 32-basepair deletion.

Authors:  J J Martinson; N H Chapman; D C Rees; Y T Liu; J B Clegg
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.

Authors:  R Srivastava; B M Keck; L E Bennett; J D Hosenpud
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

7.  Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells.

Authors:  A Kapoor; K Morita; T M Engeman; S Koga; E M Vapnek; M G Hobart; R L Fairchild
Journal:  Transplantation       Date:  2000-03-27       Impact factor: 4.939

8.  Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Qunrui Ye; Rongxiang Han; Martin E Dorf; William A Kuziel; Barrett J Rollins; Lieping Chen; Wayne W Hancock
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  The role of MIG/CXCL9 in cardiac allograft vasculopathy.

Authors:  James J Yun; Michael P Fischbein; David Whiting; Yoshihito Irie; Michael C Fishbein; Marie D Burdick; John Belperio; Robert M Strieter; Hillel Laks; Judith A Berliner; Abbas Ardehali
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

10.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

View more
  13 in total

Review 1.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

2.  Production and assessment of decellularized pig and human lung scaffolds.

Authors:  Joan E Nichols; Jean Niles; Michael Riddle; Gracie Vargas; Tuya Schilagard; Liang Ma; Kert Edward; Saverio La Francesca; Jason Sakamoto; Stephanie Vega; Marie Ogadegbe; Ronald Mlcak; Donald Deyo; Lee Woodson; Christopher McQuitty; Scott Lick; Daniel Beckles; Esther Melo; Joaquin Cortiella
Journal:  Tissue Eng Part A       Date:  2013-06-11       Impact factor: 3.845

3.  A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.

Authors:  Jeffrey J Siracuse; Mark D Fisher; Cleide G da Silva; Clayton R Peterson; Eva Csizmadia; Herwig P Moll; Scott M Damrauer; Peter Studer; Lynn Y Choi; Sanah Essayagh; Elzbieta Kaczmarek; Elizabeth R Maccariello; Andy Lee; Soizic Daniel; Christiane Ferran
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

4.  Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction.

Authors:  Sergio A Torres; Omar Cheema; Dipan J Shah; Guillermo Torre-Amione; Jerry D Estep
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

5.  Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formation.

Authors:  Milton Hamblin; Lin Chang; Hengmin Zhang; Kun Yang; Jifeng Zhang; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-18       Impact factor: 8.311

6.  The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor.

Authors:  Sabrina N Immecke; Nelli Baal; Jochen Wilhelm; Juliane Bechtel; Angela Knoche; Gregor Bein; Holger Hackstein
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 7.  Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets.

Authors:  Bin Liu; Jing Li; Lu-Nan Yan
Journal:  Clin Dev Immunol       Date:  2013-12-08

8.  Circulating chemokine ligand levels before and after successful kidney transplantation.

Authors:  Hamdi Elmoselhi; Holly Mansell; Mahmoud Soliman; Ahmed Shoker
Journal:  J Inflamm (Lond)       Date:  2016-10-26       Impact factor: 4.981

9.  Risk factors of cardiac allograft vasculopathy.

Authors:  Bożena Szyguła-Jurkiewicz; Wioletta Szczurek; Mariusz Gąsior; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-12-30

Review 10.  Transplantation and inflammation: implications for the modification of chemokine function.

Authors:  Catriona E Barker; Simi Ali; Graeme O'Boyle; John A Kirby
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.